Global Analysis

• After several quarters of flagging sales, big makers of spinal devices have started reporting a new source of pressure on the $7.1 billion market: insurance companies.
  By Jon Kamp Of DOW JONES NEWSWIRES . August 31, 2010
• FDA seeks to address industry concerns about device-approval process
  By Shawn Rhea, Modern Healthcare. August 31, 2010
• U.S. Judge Rules Against Obama’s Stem Cell Policy
  By GARDINER HARRIS, New York Times. August 23, 2010
• Pushing Back on Back Surgery
  by Aviva Mishmari . August 22, 2010
• Is It Time We Paid More Attention to Rare Diseases?
  by Aviva Mishmari . August 22, 2010
• FDA challenges stem-cell clinic
  by Aviva Mishmari . August 20, 2010
• FDA faces outcry with Avastin choice – An interesting Dilema for FDA and Industry
  By Tracy Staton, FiercePharma. August 17, 2010
• Health Care Reform Implementation Moves Forward Despite Continued Opposition
  By Kevin Kappel, Tom Koutsoumpas, and Jeremy Rabinovitz- Mintz Levine. August 17, 2010
• 1 in 5 Hospitalizations Involve Diabetes Patients
  Cheryl Clark, for HealthLeaders Media. August 16, 2010
• Medicare Reimbursement Changes May Lead to More Antibiotic Use
  Janice Simmons, for HealthLeaders Media. August 16, 2010